Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-01-16

FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)

View source ↗

Summary

FDA granted supplemental approval for Amneal Pharmaceuticals of New York LLC's generic bupropion hydrochloride (ANDA076711). The document indicates a supplement…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupropion hydrochloride (Bupropion hydrochloride)

Snippet

SUPPL AP for BUPROPION HYDROCHLORIDE (BUPROPION HYDROCHLORIDE)